To preliminarily verify the anti‐inflammation effect of MAPK6 on atherosclerosis in humans, we applied sequencing data from human plaques and ultimately used scRNA‐seq, which can distinguish endothelial cells. Here, MAPK6 is linked to atherosclerosis.